You are here: Industry Insights > Frazier

News List

Takeda and Frazier Healthcare Partners collaborate to develop clinical-stage norovirus vaccine candidate expresspharma
August 03, 2021
Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners have collaborated to launch HilleVax, Inc. (HilleVax), a biopharmaceutical company to develop and commercialise Takeda’s norovirus vaccine candidate.
Takeda and Frazier to launch HilleVax for norovirus vaccine development pharmaceutical-technology
August 02, 2021
Takeda Pharmaceutical and Frazier Healthcare Partners have partnered to launch a biopharmaceutical company named HilleVax to develop and market Takeda’s norovirus vaccine candidate, HIL-214 (previously TAK-214).
Takeda and Frazier team up to launch biopharmaceutical firm pharmaceutical-technology
May 22, 2019
Takeda Pharmaceutical has collaborated with US-based Frazier Healthcare Partners to launch a biopharmaceutical company named Phathom Pharmaceuticals.
Frazier Healthcare Partners raises $419M for life science venture fund, signaling huge interest in h biospectrumasia
November 07, 2017
The health-focused venture capital firm has announced that it has raised $419 million for its most recent life sciences investment fund, surpassing a goal of $400 million.
Merck CEO Frazier draws Trump's ire for taking stand on violence in Charlottesville fiercepharma
August 15, 2017
Merck CEO Ken Frazier has resigned from President Donald Trump's council on manufacturing in protest of the administration not taking a stronger response to racial violence in Charlottesville, Virginia.